remimazolam (Byfavo)

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Dosage

adults:

  • 5 mg IV push over 1 minute
  • supplemental doses of 2.5 mg IV over 15 seconds
  • >= 2 minutes between doses

* single-use vial containing 20 mg BYFAVO (remimazolam) lyophilized powder for reconstitution, equivalent to 27.2 mg remimazolam besylate

Adverse effects

other

* flumazenil should be immediately available during administration

Drug interactions

Mechanism of action

More general terms

References

  1. Goudra BG, Singh PM. Remimazolam: The future of its sedative potential. Saudi J Anaesth. 2014 Jul;8(3):388-91. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25191193 Free PMC article
  2. Wikipedia: Remimazolam https://en.wikipedia.org/wiki/Remimazolam
  3. HIGHLIGHTS OF PRESCRIBING INFORMATION BYFAVOTM (remimazolam) for injection, for intravenous use, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212295s000lbl.pdf

Database